HUWE1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.73712172319074E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.23150000092198E-08 |
Normal-vs-Stage2 |
7.69180052984098E-10 |
Normal-vs-Stage3 |
2.39519515332631E-12 |
Normal-vs-Stage4 |
4.32376356940267E-12 |
Stage1-vs-Stage2 |
1.499540E-02 |
Stage1-vs-Stage3 |
1.097600E-03 |
Stage1-vs-Stage4 |
3.383500E-04 |
Stage2-vs-Stage3 |
6.995600E-01 |
Stage2-vs-Stage4 |
5.533800E-01 |
Stage3-vs-Stage4 |
8.191400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.06232858252542E-12 |
Normal-vs-AfricanAmerican |
1.36550000195967E-08 |
Normal-vs-Asian |
1.693410E-01 |
Caucasian-vs-AfricanAmerican |
3.934200E-01 |
Caucasian-vs-Asian |
2.500600E-01 |
AfricanAmerican-vs-Asian |
1.827790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.18078896555107E-13 |
Normal-vs-Female |
2.26889995680324E-09 |
Male-vs-Female |
7.937900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.01890000000038E-05 |
Normal-vs-Age(41-60Yrs) |
7.07469971494845E-10 |
Normal-vs-Age(61-80Yrs) |
1.90847337933064E-12 |
Normal-vs-Age(81-100Yrs) |
1.49610000055311E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.234400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.418800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.605600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.796830E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.247570E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.354800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.035800E-01 |
Normal-vs-Grade 2 |
1.0810999873101E-09 |
Normal-vs-Grade 3 |
3.61533025738936E-12 |
Normal-vs-Grade 4 |
7.97939492258593E-12 |
Grade 1-vs-Grade 2 |
1.936460E-02 |
Grade 1-vs-Grade 3 |
8.022400E-03 |
Grade 1-vs-Grade 4 |
1.063400E-03 |
Grade 2-vs-Grade 3 |
6.298000E-02 |
Grade 2-vs-Grade 4 |
2.735500E-03 |
Grade 3-vs-Grade 4 |
1.555370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.6813999959584E-08 |
Normal-vs-ccB subtype |
8.04060151793351E-11 |
ccA subtype-vs-ccB subtype |
2.673500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.46309631077202E-11 |
Normal-vs-N1 |
3.77400000000083E-05 |
N0-vs-N1 |
4.829000E-01 |
|
|